OPN Healthcare’s Chief Medical Office, Anthony Lam, is the Principal Investigator for a phase 2b study for patients with lung cancer. This study is open for enrollment for patients with non-small cell lung cancer. Please contact Heather Lyon for a complete list of eligibility criteria and more information on participating. 

For more information on the study please see the article in Cancer Therapy Adviser